<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00936169</url>
  </required_header>
  <id_info>
    <org_study_id>AVIO</org_study_id>
    <nct_id>NCT00936169</nct_id>
  </id_info>
  <brief_title>Angiography Versus (vs) IVUS Optimisation</brief_title>
  <acronym>AVIO</acronym>
  <official_title>Angiography vs. IVUS Optimisation: A Multi-Centre European Study of Drug Eluting Stent Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mediolanum Cardio Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study id to demonstrate an advantage for intra-vascular ultrasound (IVUS)&#xD;
      optimized drug-eluting stent (DES) implantation compared to angiography in complex lesions&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-procedure Minimal Lumen Diameter (MLD) evaluated by core lab QCA: superiority for the IVUS optimised group.</measure>
    <time_frame>Procedure day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation (TLR) at 9 months: superiority or statistical trend for the IVUS optimized group</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (MACE) at 9 months: superiority or statistical trend for the IVUS guided group due to lower TLR and no difference in myocardial infarction (MI) or death.</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE events at 2 years.</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">284</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>IVUS optimised stent implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>angiographically guided DES implantation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IVUS optimised DES implantation</intervention_name>
    <description>Ivus optimised stent implantation</description>
    <arm_group_label>IVUS optimised stent implantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>angiographically guided DES implantation</intervention_name>
    <description>angiographically guided DES implantation</description>
    <arm_group_label>angiographically guided DES implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A complex lesion is regarded as a lesion where the operator would expect a lower&#xD;
             immediate and long term success rate compared to non-complex lesions (according to the&#xD;
             results of Randomized Controlled Trials and from large Registries). The operator must&#xD;
             consider the implantation of a drug-eluting stent, feasible and appropriate for this&#xD;
             particular complex lesion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contra-indication to dual anti-platelet therapy.&#xD;
&#xD;
          -  Ejection fraction &lt;30%.&#xD;
&#xD;
          -  Renal failure (creatinine &gt;2 mg/dL).&#xD;
&#xD;
          -  Significant co-morbidity precluding clinical follow-up.&#xD;
&#xD;
          -  Acute myocardial infarction in the 48 hours prior to the procedure.&#xD;
&#xD;
          -  In-stent restenosis&#xD;
&#xD;
          -  Prior brachytherapy&#xD;
&#xD;
          -  Thrombocytopenia &lt;100,000&#xD;
&#xD;
          -  Unprotected left main stem stenosis&#xD;
&#xD;
          -  Venous or arterial grafts&#xD;
&#xD;
          -  Recipient of heart transplant&#xD;
&#xD;
          -  A positive pregnancy test in women with child bearing potential&#xD;
&#xD;
          -  Acute infections&#xD;
&#xD;
          -  Major surgery planned which will lead to discontinuation of antiplatelet therapy&#xD;
&#xD;
          -  Patients with prior BMS or DES implanted in the target vessel less than one year prior&#xD;
             to the enrollment, including one year from any intercurrent restenotic or thrombotic&#xD;
             event&#xD;
&#xD;
          -  Age under 18 years old.&#xD;
&#xD;
          -  There is no maximum number of lesions which can be treated&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>July 8, 2009</study_first_submitted>
  <study_first_submitted_qc>July 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2009</study_first_posted>
  <last_update_submitted>February 20, 2012</last_update_submitted>
  <last_update_submitted_qc>February 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Patients with at least one complex lesion suitable for implantation of a drug-eluting stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

